IL22 and neoplasm: Once in close proximity to the tumor cells, these Tc17 cells engage in a reciprocal signaling cascade, secreting interleukins (IL-16, IL17, IL-22, and IL-26), thereby forming a vicious cycle that promotes the progression of tumor cells (Figure 5).